bioRxiv preprint doi: https://doi.org/10.1101/2021.02.18.431828; this version posted February 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Intracellular NASPM allows an unambiguous functional measure of 2 GluA2-lacking calcium-permeable AMPA receptor prevalence 3 Ian D. Coombs, Cécile Bats, Craig A. Sexton, Stuart G. Cull-Candy* and 4 Mark Farrant* 5 Department of Neuroscience, Physiology, and Pharmacology, University College 6 London, London WC1E 6BT, United Kingdom 7 *Authors for correspondence: 8 Stuart G. Cull-Candy (
[email protected]), Mark Farrant (
[email protected]). 9 Acknowledgements: 10 This work was supported by an MRC Programme Grant (MR/T002506/1) to MF and 11 SGCC. 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.02.18.431828; this version posted February 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 12 Abstract 13 Calcium-permeable AMPA-type glutamate receptors (CP-AMPARs) contribute to 14 many forms of synaptic plasticity and pathology. They can be distinguished from 15 GluA2-containing calcium-impermeable AMPARs by the inward rectification of their 16 currents, which reflects voltage-dependent block by intracellular spermine. However, 17 the efficacy of this weakly permeant blocker is differentially altered by the presence of 18 AMPAR auxiliary subunits – including transmembrane AMPAR regulatory proteins, 19 cornichons and GSG1L – that are widely expressed in neurons and glia.